Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

sethmarcus Jun. 16 at 10:34 AM

The pullback in Health Care $XLV is normal and to be expected. The run to $154 from $142 delivered overheated conditions that usually present profit taking and an opportunity to buy the dip thereafter. Playing out exactly as we had forecast and disseminated to Finom Group members a week ago, inside our macro-market Research Report $LLY $SPY $AMGN $PFE

0 · Reply

GoParabolic Jun. 16 at 9:29 AM

$BNTX will move fast and surprise $NVDA $TSLA $SPCX $PFE

0 · Reply

BioRich Jun. 16 at 4:42 AM

$SABS As this has all the feels of breaking out, I decided to look at the management team. Strong. In particular, I like a Chief Medical Officer with the experience and Big Pharma ties that $SABS's CMO has. $TEVA $SNY $PFE $IBIO . Looks good to me. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!

0 · Reply

StUngarjr Jun. 15 at 10:15 PM

$PFE This is a bond don’t confuse it for a stock. It’s all about expectations. Actually, a very good bond as it pays well like Verizon. Just don’t confuse it for a stock. If your expectations are for appreciation, you’re delusional. It is possible in time like Verizon but certainly wouldn’t count on it. It lists under equities , but that’s only to fool naive newbies and older people who think they’re conservative when actually they’re …Let’s just say slow upstairs🤯🙄

2 · Reply

MoneyFairyBlessings Jun. 15 at 9:39 PM

$PLTR $NKE $PFE $MNTS A few things stopping « people » from 🎁💎🎁💎🎁💎s : 1. They do not see value. 2. They only chase after fluff. 3. Fear and fanfare- driven.

0 · Reply

DisMania Jun. 15 at 8:58 PM

$PFE $SOFI This guy has the same behavior in every ticker - he pretends to be a disillusioned bull who made the wrong choice. Wonder who's paying this guy. If what he says is true, he's even more pathetic than I thought 😂😂😂 But I doubt it, pretty sure somebody is paying him to post. Either way, he's a tool.

1 · Reply

A_Train1 Jun. 15 at 8:52 PM

$PFE if I had been smart, I would’ve sold the stock at the end of last year, and put it all into Sandisk when it popped up on the trending line in the 50s. That trending signal was a GIFT. I didn’t take the gift. I could’ve had $2 million right now instead of shares of a questionable pharmaceutical company with questionable leadership and a healthy dividend. And, I could’ve come back and bought those shares back and not lost a beat.

1 · Reply

MoneyFairyBlessings Jun. 15 at 8:21 PM

$PLTR $PLTR $NKE $PFE $MNTS This market is filled with day traders who capture incremental of pennies. Dare to aim higher and dare to think bigger?💰🎁💎😀🔥💰💚

1 · Reply

PFElinepfrenzy1990 Jun. 15 at 8:08 PM

$PFE - Thank you Metsera 🥰

2 · Reply

Micheal_Pothead Jun. 15 at 8:00 PM

$PFE I wish Albert was a mute

0 · Reply

Pfizer CEO warns German investment at risk over drug pricing policies

2026-06-09T21:05:52.000Z - 6 days ago

Pfizer upgraded to Sector Perform from Underperform at RBC Capital

2026-06-09T21:05:12.000Z - 6 days ago

Pfizer upgraded to Sector Perform at RBC Capital amid more balanced risk-reward

Jun 9, 2026, 2:07 PM EDT - 6 days ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 6 days ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 7 days ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 7 days ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

2026-06-08T10:51:57.000Z - 8 days ago

Pfizer says FDA approves expanded indication for Hympavzi

Jun 8, 2026, 6:49 AM EDT - 8 days ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 8 days ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

2026-06-07T22:00:49.000Z - 8 days ago

Pfizer presents results from Phase 2b studies of berobenatide

Jun 6, 2026, 11:00 AM EDT - 9 days ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 9 days ago

Pfizer Slides: Study update

Jun 6, 2026, 9:06 AM EDT - 9 days ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 9 days ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 11 days ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 12 days ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 12 days ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 14 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

2026-05-31T13:45:07.000Z - 15 days ago

Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri

2026-05-31T13:25:52.000Z - 15 days ago

Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi

May 31, 2026, 8:00 AM EDT - 15 days ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 9:22 AM EDT - 16 days ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA

May 30, 2026, 8:00 AM EDT - 16 days ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

2026-05-29T13:17:15.000Z - 17 days ago

Pfizer announces seven-year follow-up results from Phase 3 CROWN trial

May 29, 2026, 8:00 AM EDT - 17 days ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 18 days ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 18 days ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

2026-05-28T23:05:16.000Z - 18 days ago

Pfizer enters into global strategic collaboration with Innovent Biologics

May 28, 2026, 7:00 PM EDT - 18 days ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 18 days ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

2026-05-28T12:35:12.000Z - 18 days ago

Guardant Health to present 38 abstracts at ASCO 2026 meeting

May 27, 2026, 10:00 AM EDT - 19 days ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 20, 2026, 9:00 AM EDT - 26 days ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 5:08 AM EDT - 27 days ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 27 days ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 18, 2026, 8:00 AM EDT - 4 weeks ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 14, 2026, 2:22 PM EDT - 4 weeks ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

May 13, 2026, 6:45 AM EDT - 4 weeks ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 12, 2026, 8:00 AM EDT - 4 weeks ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

May 12, 2026, 7:00 AM EDT - 5 weeks ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

May 5, 2026, 4:09 PM EDT - 5 weeks ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:02 PM EDT - 5 weeks ago

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 11:30 AM EDT - 5 weeks ago

3 Dividend Stocks for May 2026

SYY WSO

May 5, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Slides: Q1 2026

May 5, 2026, 8:35 AM EDT - 5 weeks ago

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 7:23 AM EDT - 5 weeks ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:06 AM EDT - 6 weeks ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:05 AM EDT - 6 weeks ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

May 5, 2026, 6:55 AM EDT - 6 weeks ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:51 AM EDT - 6 weeks ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 1, 2026, 12:37 PM EDT - 6 weeks ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Apr 29, 2026, 7:42 AM EDT - 6 weeks ago

Pfizer's blood cancer drug meets main goal in late-stage trial

$Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma$

Apr 29, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 28, 2026, 10:41 AM EDT - 6 weeks ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:17 AM EDT - 6 weeks ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 24, 2026, 8:36 AM EDT - 7 weeks ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Apr 23, 2026, 9:00 AM EDT - 7 weeks ago

Pfizer Transcript: AGM 2026

Apr 22, 2026, 4:45 PM EDT - 7 weeks ago

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 5:18 AM EDT - 7 weeks ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 21, 2026, 11:51 AM EDT - 7 weeks ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 20, 2026, 3:05 PM EDT - 2 months ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 16, 2026, 1:01 PM EDT - 2 months ago

The Big 3: PFE, V, SYF

SYF V

sethmarcus Jun. 16 at 10:34 AM

0 · Reply

GoParabolic Jun. 16 at 9:29 AM

$BNTX will move fast and surprise $NVDA $TSLA $SPCX $PFE

0 · Reply

BioRich Jun. 16 at 4:42 AM

0 · Reply

StUngarjr Jun. 15 at 10:15 PM

2 · Reply

MoneyFairyBlessings Jun. 15 at 9:39 PM

$PLTR $NKE $PFE $MNTS A few things stopping « people » from 🎁💎🎁💎🎁💎s : 1. They do not see value. 2. They only chase after fluff. 3. Fear and fanfare- driven.

0 · Reply

DisMania Jun. 15 at 8:58 PM

1 · Reply

A_Train1 Jun. 15 at 8:52 PM

1 · Reply

MoneyFairyBlessings Jun. 15 at 8:21 PM

$PLTR $PLTR $NKE $PFE $MNTS This market is filled with day traders who capture incremental of pennies. Dare to aim higher and dare to think bigger?💰🎁💎😀🔥💰💚

1 · Reply

PFElinepfrenzy1990 Jun. 15 at 8:08 PM

$PFE - Thank you Metsera 🥰

2 · Reply

Micheal_Pothead Jun. 15 at 8:00 PM

$PFE I wish Albert was a mute

0 · Reply

pasuny Jun. 15 at 7:57 PM

$PFE Disgusting scam operation.

0 · Reply

Micheal_Pothead Jun. 15 at 7:49 PM

$PFE genuinely the worst to ever do it

0 · Reply

JBS_84 Jun. 15 at 7:10 PM

$PFE probably close around 26.21

3 · Reply

simonds Jun. 15 at 7:07 PM

$PFE This thing going back under $24.50

2 · Reply

TraderDaKing Jun. 15 at 6:45 PM

$ELTP $PFE $GME $AMC ROARING KITTY KNOWS SOMETHING Elite Pharmaceuticals announced positive results from a pivotal bioequivalence study for an undisclosed generic anticonvulsant drug. The branded version generated $840 million in sales over the last 12 months.

1 · Reply

dust6431 Jun. 15 at 6:41 PM

$PFE Message from the sreet....Hope is a dangerous thing

0 · Reply

Micheal_Pothead Jun. 15 at 6:18 PM

$PFE SpaceX is up 2 Pfizer’s today 🫩

3 · Reply

simonds Jun. 15 at 6:06 PM

$PFE Ha Ha

0 · Reply

Sjs360 Jun. 15 at 5:59 PM

$BSX $PFE $TTD $NTDOY All my stocks are red.

0 · Reply

Micheal_Pothead Jun. 15 at 5:58 PM

$PFE looool

0 · Reply

MrPeanutEsquire Jun. 15 at 5:39 PM

$PFE Great

1 · Reply

ForestGump1776 Jun. 15 at 4:22 PM

$PFE Tracking nicely with SPY. SPY up 2 percent, PFE up .2 percent. Life changing gains here, $26.50 still in play this week 😂 .

0 · Reply

Market Cap	149.38B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.55
Forward PE	8.76
Profit Margin	12.42%
Debt to Equity Ratio	0.71

Volume	34,194,100
Avg Vol	34,869,105
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	77%
Beta	0.34
Analysts	Sell
Price Target	$29.28